Evidence map›Paper›PMID 22742734›Full record

ArticleCritical care (London, England)2012

A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis.

Jonathan S Boomer, Jennifer Shuherk-Shaffer, Richard S Hotchkiss, Jonathan M Green

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 3 syntheses or guidelines pooled it, 242 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Persistent lymphopaenia in critically ill patients with and without sepsis: An Australian and New Zealand point prevalence study.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026
    Article
  7. Factors associated withJournal of thoracic disease · 2026
    Article
  8. Review
  9. Article
  10. TIM-3, a potential target for sepsis therapy.Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Admission CD4Frontiers in cellular and infection microbiology · 2026
    Observational
  15. Article
  16. Review
  17. Peri-Operative Antimicrobial Prophylaxis Modulates CD4Antibiotics (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Article
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jonathan S Boomer
Jennifer Shuherk-Shaffer
Richard S Hotchkiss
Jonathan M Green
Washington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Prevention of Apoptotic Cell Death in Sepsis by BCL-2R37GM044118 · NIGMS · WASHINGTON UNIVERSITY · PI HOTCHKISS, RICHARD SAMUEL · 2003 to 2012
$5.1M
CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURER01GM055194 · NIGMS · WASHINGTON UNIVERSITY · PI HOTCHKISS, RICHARD SAMUEL · 1997 to 2012
$4.7M
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2R01GM044118 · NIGMS · WASHINGTON UNIVERSITY · PI HOTCHKISS, RICHARD SAMUEL · 1992 to 2017
$2.7M
MECHANISMS OF IMMUNOSUPPRESSION IN SEPSISR01GM098391 · NIGMS · WASHINGTON UNIVERSITY · PI GREEN, JONATHAN M., HOTCHKISS, RICHARD SAMUEL · 2012 to 2015
$2.2M
IMMUNOLOGIC BASIS FOR SUSCEPTIBILITY TO SECONDARY INFECTIONS IN SEVERE SEPSISR21HL104985 · NHLBI · WASHINGTON UNIVERSITY · PI GREEN, JONATHAN M. · 2010 to 2011
$418k
NCI NIH HHS #P30 CA91842NCRR NIH HHS UL1 RR024992NHLBI NIH HHS R21 HL104985NHLBI NIH HHS R21HL104985NIGMS NIH HHS GM044118NIGMS NIH HHS GM055194NIGMS NIH HHS R01 GM098391
6 · The paper itself

Abstract

introductionSevere sepsis is characterized by an initial hyper-inflammatory response that may progress to an immune-suppressed state associated with increased susceptibility to nosocomial infection. Analysis of samples obtained from patients who died of sepsis has identified expression of specific inhibitory receptors expressed on lymphocytes that are associated with cell exhaustion. The objective of this study was to prospectively determine the pattern of expression of these receptors and immune cell function in patients with acute sepsis.

methodsTwenty-four patients with severe sepsis were enrolled within 24 hours of the onset of sepsis, as were 12 age-matched healthy controls. Peripheral blood was obtained at enrollment and again seven days later. Immune cell subsets and receptor expression were extensively characterized by quantitative flow cytometry. Lymphocyte function was assayed by stimulated cytokine secretion and proliferation assays. Results were also correlated to clinical outcome.

resultsAt the onset of severe sepsis, patients had decreased circulating innate and adaptive immune cells and elevated lymphocyte expression of receptors associated with cell activation compared to controls. Samples analyzed seven days later demonstrated increased expression of the inhibitory receptors CTLA4, TIM-3 and LAG-3 on T lymphocytes accompanied by decreased expression of the IL-7 receptor. Functional assays revealed impaired secretion of interferon γ following stimulation in vitro, which was reversible by incubation overnight in fresh media. Impaired secretion of IFNγ correlated with death or development of secondary infection.

conclusionsLymphocytes from patients with acute sepsis upregulate expression of receptors associated with cell exhaustion, which may contribute to the immune suppressed state that occurs in protracted disease. Therapy that reverses T cell exhaustion may restore immune function in immunocompromised patients and improve survival in sepsis.

Indexed as

PhenotypeAcute DiseaseAdultAgedAged, 80 and overFemaleFlow CytometryHumansIntensive Care UnitsLymphocytesMaleMiddle AgedProspective StudiesSepsis

Identifiers

PMID22742734
PMCPMC3580670
OpenAlexW2158510250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.